| First Author | Teuscher C | Year | 1996 |
| Journal | J Exp Med | Volume | 183 |
| Issue | 2 | Pages | 631-7 |
| PubMed ID | 8627174 | Mgi Jnum | J:31314 |
| Mgi Id | MGI:78817 | Doi | 10.1084/jem.183.2.631 |
| Citation | Teuscher C, et al. (1996) Aod2, the locus controlling development of atrophy in neonatal thymectomy-induced autoimmune ovarian dysgenesis, co-localizes with Il2, Fgfb, and Idd3. J Exp Med 183(2):631-7 |
| abstractText | In genetically susceptible strains of mice, such as A/J and (C57BL/6J x A/J)F1 hybrids, neonatal thymectomy-induced autoimmune ovarian dysgenesis (AOD) is characterized by the development of antiovarian autoantibodies, oophoritis, and atrophy. Temporally, atrophy may be observed during and after the regression of inflammatory infiltrates from the ovary. Histologically, lesions appear as areas devoid of ovarian follicles in all stages of development that have been replaced by luteinized interstitial cells. We report here the mapping of Aod2, the locus that controls this phenotype, to mouse chromosomes 3 within a region encoding Il2 and Fgfb. Most significant, however, is the co-localization of Aod2 to Idd3, a susceptibility gene that plays a role in autoimmune insulin-dependent type 1 diabetes mellitus in the nonobese diabetic mouse. |
